Gossamer Bio, Inc.
US ˙ NasdaqGS ˙ US38341P1021

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Bilenker Joshua H.. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Bilenker Joshua H. har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:SANA / Sana Biotechnology, Inc. Director 20.000
US:GOSS / Gossamer Bio, Inc. Director 23.500
US:LOXO / Loxo Oncology, Inc. President & CEO, Director 0
US:VRAY / ViewRay Inc. Director, 10% Owner 18.964
US:TTOO / T2 Biosystems, Inc. Director 17.647
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Bilenker Joshua H.. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb GOSS / Gossamer Bio, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i GOSS / Gossamer Bio, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

GOSS / Gossamer Bio, Inc. Insider Trades
Insidersalg GOSS / Gossamer Bio, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i GOSS / Gossamer Bio, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

GOSS / Gossamer Bio, Inc. Insider Trades
Insiderkøb SANA / Sana Biotechnology, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i GOSS / Gossamer Bio, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2021-02-03 SANA Bilenker Joshua H. 20.000 25,0000 20.000 25,0000 500.000 7 43.5 370.000 74,00

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

SANA / Sana Biotechnology, Inc. Insider Trades
Insidersalg SANA / Sana Biotechnology, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i GOSS / Gossamer Bio, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

SANA / Sana Biotechnology, Inc. Insider Trades
Insiderkøb VRAYQ / ViewRay, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i GOSS / Gossamer Bio, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

VRAYQ / ViewRay, Inc. Insider Trades
Insidersalg VRAYQ / ViewRay, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i GOSS / Gossamer Bio, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

VRAYQ / ViewRay, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Bilenker Joshua H. som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2023-02-17 2021-02-03 4 SANA Sana Biotechnology, Inc.
Common Stock
P - Purchase 20.000 20.000 25,00 500.000 500.000
2021-06-10 2021-06-09 4 GOSS Gossamer Bio, Inc.
Stock Option (Right to Buy)
A - Award 23.500 23.500
2021-02-05 2021-02-03 4 SANA Sana Biotechnology, Inc.
Stock Option (Right to Buy)
A - Award 7.000 7.000
2020-06-18 2020-06-17 4 GOSS Gossamer Bio, Inc.
Stock Option (right to buy)
A - Award 23.500 23.500
2019-06-11 2019-06-10 4 GOSS Gossamer Bio, Inc.
Stock Option (right to buy)
A - Award 23.500 23.500
2019-02-15 2019-02-15 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
D - Sale to Issuer -128.000 0 -100,00 235,00 -30.080.000
2019-02-15 2019-02-15 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
D - Sale to Issuer -300.000 0 -100,00 235,00 -70.500.000
2019-02-15 2019-02-15 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
D - Sale to Issuer -100.000 0 -100,00 235,00 -23.500.000
2019-02-15 2019-02-15 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
D - Sale to Issuer -209.000 0 -100,00 235,00 -49.115.000
2019-02-15 2019-02-15 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
D - Sale to Issuer -142.000 0 -100,00 235,00 -33.370.000
2019-02-15 2019-02-15 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
D - Sale to Issuer -318.514 0 -100,00 235,00 -74.850.790
2019-02-15 2019-02-15 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
D - Sale to Issuer -64.471 0 -100,00 235,00 -15.150.685
2019-02-15 2019-02-15 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
D - Sale to Issuer -27.459 0 -100,00 235,00 -6.452.865
2019-02-15 2019-02-15 4 LOXO Loxo Oncology, Inc.
Common Stock
D - Sale to Issuer -30.000 0 -100,00 235,00 -7.050.000
2019-02-15 2019-02-15 4 LOXO Loxo Oncology, Inc.
Common Stock
D - Sale to Issuer -162.707 0 -100,00 235,00 -38.236.145
2019-01-17 2018-07-09 4/A LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 7.500 141.207 5,61 1,18 8.880 167.189
2019-01-02 2019-01-02 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
A - Award 128.000 128.000
2018-12-12 2018-12-11 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
M - Exercise X -10.000 318.514 -3,04
2018-12-12 2018-12-11 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -100 164.407 -0,06 140,61 -14.061 23.117.268
2018-12-12 2018-12-11 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1.200 164.507 -0,72 140,15 -168.180 23.055.656
2018-12-12 2018-12-11 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1.100 165.707 -0,66 139,05 -152.955 23.041.558
2018-12-12 2018-12-11 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -2.407 166.807 -1,42 137,63 -331.275 22.957.647
2018-12-12 2018-12-11 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -3.393 169.214 -1,97 136,79 -464.128 23.146.783
2018-12-12 2018-12-11 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1.153 172.607 -0,66 135,76 -156.531 23.433.126
2018-12-12 2018-12-11 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -647 173.760 -0,37 134,63 -87.106 23.393.309
2018-12-12 2018-12-11 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 10.000 174.407 6,08 13,67 136.700 2.384.144
2018-12-12 2018-12-10 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
M - Exercise X -10.000 328.514 -2,95
2018-12-12 2018-12-10 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -100 164.407 -0,06 137,39 -13.739 22.587.878
2018-12-12 2018-12-10 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -400 164.507 -0,24 136,48 -54.592 22.451.915
2018-12-12 2018-12-10 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -2.377 164.907 -1,42 135,04 -320.990 22.269.041
2018-12-12 2018-12-10 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -2.049 167.284 -1,21 134,31 -275.201 22.467.914
2018-12-12 2018-12-10 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -2.104 169.333 -1,23 133,00 -279.832 22.521.289
2018-12-12 2018-12-10 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -2.001 171.437 -1,15 132,09 -264.312 22.645.113
2018-12-12 2018-12-10 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -969 173.438 -0,56 130,58 -126.532 22.647.534
2018-12-12 2018-12-10 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 10.000 174.407 6,08 13,67 136.700 2.384.144
2018-11-28 2018-11-27 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
M - Exercise X -10.000 338.514 -2,87
2018-11-28 2018-11-27 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -200 164.407 -0,12 151,56 -30.312 24.917.525
2018-11-28 2018-11-27 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -400 164.607 -0,24 149,25 -59.700 24.567.595
2018-11-28 2018-11-27 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -250 165.007 -0,15 148,06 -37.015 24.430.936
2018-11-28 2018-11-27 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -600 165.257 -0,36 147,09 -88.254 24.307.652
2018-11-28 2018-11-27 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -700 165.857 -0,42 144,61 -101.227 23.984.581
2018-11-28 2018-11-27 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -859 166.557 -0,51 143,35 -123.138 23.875.946
2018-11-28 2018-11-27 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -634 167.416 -0,38 142,45 -90.313 23.848.409
2018-11-28 2018-11-27 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -690 168.050 -0,41 141,48 -97.621 23.775.714
2018-11-28 2018-11-27 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -700 168.740 -0,41 140,14 -98.098 23.647.224
2018-11-28 2018-11-27 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -2.638 169.440 -1,53 138,94 -366.524 23.541.994
2018-11-28 2018-11-27 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -2.329 172.078 -1,34 137,92 -321.216 23.732.998
2018-11-28 2018-11-27 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 10.000 174.407 6,08 13,67 136.700 2.384.144
2018-11-28 2018-11-26 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
M - Exercise X -1.486 348.514 -0,42
2018-11-28 2018-11-26 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
M - Exercise X -8.514 64.471 -11,67
2018-11-28 2018-11-26 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
M - Exercise X -29.000 27.459 -51,36
2018-11-28 2018-11-26 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -664 164.407 -0,40 156,20 -103.717 25.680.373
2018-11-28 2018-11-26 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -2.210 165.071 -1,32 155,08 -342.727 25.599.211
2018-11-28 2018-11-26 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -676 167.281 -0,40 154,07 -104.151 25.772.984
2018-11-28 2018-11-26 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1.995 167.957 -1,17 152,75 -304.736 25.655.432
2018-11-28 2018-11-26 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -3.655 169.952 -2,11 152,04 -555.706 25.839.502
2018-11-28 2018-11-26 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -800 173.607 -0,46 150,99 -120.792 26.212.921
2018-11-28 2018-11-26 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 1.486 174.407 0,86 13,67 20.314 2.384.144
2018-11-28 2018-11-26 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 8.514 172.921 5,18 3,65 31.059 630.816
2018-11-28 2018-11-26 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 29.000 164.407 21,42 1,18 34.336 194.658
2018-10-05 2018-10-04 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
M - Exercise X -10.000 72.985 -12,05
2018-10-05 2018-10-04 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -200 135.407 -0,15 165,57 -33.114 22.419.188
2018-10-05 2018-10-04 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1.395 135.607 -1,02 164,59 -229.606 22.319.841
2018-10-05 2018-10-04 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -2.000 137.002 -1,44 163,64 -327.286 22.419.391
2018-10-05 2018-10-04 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -3.152 139.002 -2,22 162,60 -512.528 22.602.295
2018-10-05 2018-10-04 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1.553 142.154 -1,08 161,41 -250.669 22.945.020
2018-10-05 2018-10-04 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1.700 143.707 -1,17 160,61 -273.043 23.081.327
2018-10-05 2018-10-04 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 10.000 145.407 7,39 3,65 36.480 530.445
2018-10-05 2018-10-03 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
M - Exercise X -10.000 82.985 -10,75
2018-10-05 2018-10-03 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -195 135.407 -0,14 169,68 -33.087 22.975.575
2018-10-05 2018-10-03 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -3.705 135.602 -2,66 169,00 -626.156 22.917.145
2018-10-05 2018-10-03 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1.297 139.307 -0,92 168,29 -218.272 23.444.003
2018-10-05 2018-10-03 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -673 140.604 -0,48 167,09 -112.452 23.493.635
2018-10-05 2018-10-03 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1.225 141.277 -0,86 165,95 -203.286 23.444.593
2018-10-05 2001-10-03 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -2.905 142.502 -2,00 165,01 -479.342 23.513.657
2018-10-05 2001-10-03 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 10.000 145.407 7,39 3,65 36.480 530.445
2018-09-14 2018-09-13 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
M - Exercise X -2.527 92.985 -2,65
2018-09-14 2018-09-13 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
M - Exercise X -7.473 56.459 -11,69
2018-09-14 2018-09-13 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -962 135.407 -0,71 167,32 -160.959 22.655.879
2018-09-14 2018-09-13 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -3.402 136.369 -2,43 166,52 -566.511 22.708.575
2018-09-14 2018-09-13 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -5.636 139.771 -3,88 165,42 -932.335 23.121.618
2018-09-14 2018-09-13 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 2.527 145.407 1,77 3,65 9.218 530.445
2018-09-14 2018-09-13 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 7.473 142.880 5,52 1,18 8.848 169.170
2018-09-14 2018-09-12 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
M - Exercise X -10.000 63.932 -13,53
2018-09-14 2018-09-12 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -400 135.407 -0,29 171,08 -68.430 23.164.753
2018-09-14 2018-09-12 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -200 135.807 -0,15 169,89 -33.977 23.071.871
2018-09-14 2018-09-12 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -800 136.007 -0,58 168,51 -134.810 22.918.880
2018-09-14 2018-09-12 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1.800 136.807 -1,30 167,38 -301.287 22.898.947
2018-09-14 2018-09-12 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -2.400 138.607 -1,70 166,49 -399.570 23.076.333
2018-09-14 2018-09-12 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -3.700 141.007 -2,56 165,18 -611.174 23.291.832
2018-09-14 2018-09-12 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -700 144.707 -0,48 164,16 -114.912 23.755.014
2018-09-14 2018-09-12 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 10.000 145.407 7,39 1,18 11.840 172.162
2018-08-15 2018-08-14 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
M - Exercise X -10.000 73.932 -11,91
2018-08-15 2018-08-14 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1.300 135.407 -0,95 160,75 -208.976 21.766.784
2018-08-15 2018-08-14 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -7.100 136.707 -4,94 159,93 -1.135.511 21.863.701
2018-08-15 2018-08-14 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1.600 143.807 -1,10 159,13 -254.602 22.883.476
2018-08-15 2018-08-14 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 10.000 145.407 7,39 1,18 11.840 172.162
2018-08-15 2018-08-13 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
M - Exercise X -10.000 83.932 -10,65
2018-08-15 2018-08-13 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -800 135.407 -0,59 160,49 -128.389 21.730.955
2018-08-15 2018-08-13 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -3.367 136.207 -2,41 159,63 -537.463 21.742.274
2018-08-15 2018-08-13 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -4.233 139.574 -2,94 158,51 -670.972 22.123.847
2018-08-15 2018-08-13 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1.600 143.807 -1,10 157,67 -252.268 22.673.719
2018-08-15 2018-08-13 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 10.000 145.407 7,39 1,18 11.840 172.162
2018-07-11 2018-07-10 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise X -7.500 93.932 -7,39
2018-07-11 2018-07-10 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -800 135.407 -0,59 182,84 -146.271 24.757.653
2018-07-11 2018-07-10 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1.300 136.207 -0,95 181,21 -235.570 24.681.757
2018-07-11 2018-07-10 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1.000 137.507 -0,72 180,08 -180.081 24.762.398
2018-07-11 2018-07-10 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -2.200 138.507 -1,56 179,08 -393.978 24.803.958
2018-07-11 2018-07-10 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -2.200 140.707 -1,54 178,19 -392.023 25.072.904
2018-07-11 2018-07-10 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 7.500 142.907 5,54 1,18 8.880 169.202
2018-07-11 2018-07-09 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise X -7.500 101.432 -6,89
2018-07-11 2018-07-09 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -300 135.407 -0,22 191,63 -57.490 25.948.490
2018-07-11 2018-07-09 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -300 135.707 -0,22 189,43 -56.829 25.706.977
2018-07-11 2018-07-09 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -802 136.007 -0,59 188,28 -151.004 25.608.064
2018-07-11 2018-07-09 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -3.698 136.809 -2,63 187,39 -692.957 25.636.242
2018-07-11 2018-07-09 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1.500 140.507 -1,06 186,38 -279.577 26.188.383
2018-07-11 2018-07-09 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -900 142.007 -0,63 184,87 -166.383 26.252.806
2018-07-11 2018-07-09 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 7.500 142.907 5,54 1,18 8.880 169.202
2018-06-21 2018-06-20 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise X -7.500 108.932 -6,44
2018-06-21 2018-06-20 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise -28.000 116.432 -19,39
2018-06-21 2018-06-20 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale -9.664 8.000 -54,71 179,77 -1.737.326 1.438.184
2018-06-21 2018-06-20 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale -11.336 17.664 -39,09 178,94 -2.028.506 3.160.862
2018-06-21 2018-06-20 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -430 155.707 -0,28 180,90 -77.785 28.166.851
2018-06-21 2018-06-20 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -4.370 156.137 -2,72 179,37 -783.846 28.006.247
2018-06-21 2018-06-20 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -2.700 160.507 -1,65 178,81 -482.774 28.699.486
2018-06-21 2018-06-20 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 7.500 163.207 4,82 1,18 8.880 193.237
2018-06-21 2018-06-20 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise 28.000 155.707 21,93 1,18 33.152 184.357
2018-06-21 2018-06-19 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise X -7.500 144.432 -4,94
2018-06-21 2018-06-19 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale -103 29.000 -0,35 180,34 -18.575 5.229.767
2018-06-21 2018-06-19 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale -3.902 29.103 -11,82 179,83 -701.710 5.233.689
2018-06-21 2018-06-19 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale -8.763 33.005 -20,98 178,30 -1.562.417 5.884.692
2018-06-21 2018-06-19 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale -8.232 41.768 -16,46 177,44 -1.460.652 7.411.143
2018-06-21 2018-06-19 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1.737 127.707 -1,34 178,12 -309.390 22.746.813
2018-06-21 2018-06-19 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -3.427 129.444 -2,58 177,06 -606.770 22.918.785
2018-06-21 2018-06-19 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -2.336 132.871 -1,73 176,20 -411.607 23.412.083
2018-06-21 2018-06-19 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 7.500 135.207 5,87 1,18 8.880 160.085
2018-06-21 2018-06-08 4 LOXO Loxo Oncology, Inc.
Common Stock
G - Gift -5.000 127.707 -3,77
2018-05-16 2018-05-15 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise X -7.500 14.690 -33,80
2018-05-16 2018-05-15 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1.803 182.707 -0,98 138,89 -250.416 25.375.865
2018-05-16 2018-05-15 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -3.297 184.510 -1,76 138,35 -456.147 25.527.346
2018-05-16 2018-05-15 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -400 187.807 -0,21 136,72 -54.688 25.676.973
2018-05-16 2018-05-15 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1.000 188.207 -0,53 135,83 -135.828 25.563.780
2018-05-16 2018-05-15 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -300 189.207 -0,16 134,41 -40.322 25.430.688
2018-05-16 2018-05-15 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -700 189.507 -0,37 133,11 -93.175 25.224.613
2018-05-16 2018-05-15 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 7.500 190.207 4,10 1,18 8.880 225.205
2018-05-16 2018-05-14 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise X -7.500 22.190 -25,26
2018-05-16 2018-05-14 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -100 182.707 -0,05 139,00 -13.900 25.396.584
2018-05-16 2018-05-14 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -167 182.807 -0,09 137,83 -23.018 25.196.636
2018-05-16 2018-05-14 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1.558 182.974 -0,84 137,28 -213.876 25.117.994
2018-05-16 2018-05-14 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1.525 184.532 -0,82 136,22 -207.730 25.136.322
2018-05-16 2018-05-14 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -2.050 186.057 -1,09 135,08 -276.920 25.133.082
2018-05-16 2018-05-14 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -2.000 188.107 -1,05 134,18 -268.369 25.241.044
2018-05-16 2018-05-14 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -100 190.107 -0,05 132,58 -13.258 25.204.386
2018-05-16 2018-05-14 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 7.500 190.207 4,10 1,18 8.880 225.205
2018-04-26 2018-04-25 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise X -7.500 29.690 -20,17
2018-04-26 2018-04-25 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -100 182.707 -0,05 132,53 -13.253 24.214.159
2018-04-26 2018-04-25 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -3.400 182.807 -1,83 131,84 -448.262 24.101.604
2018-04-26 2018-04-25 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -2.400 186.207 -1,27 130,71 -313.709 24.339.508
2018-04-26 2018-04-25 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -800 188.607 -0,42 129,44 -103.555 24.414.007
2018-04-26 2018-04-25 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -800 189.407 -0,42 128,30 -102.644 24.301.770
2018-04-26 2018-04-25 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 7.500 190.207 4,10 1,18 8.880 225.205
2018-04-26 2018-04-24 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise X -7.500 37.190 -16,78
2018-04-26 2018-04-24 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -510 182.707 -0,28 133,49 -68.077 24.388.662
2018-04-26 2018-04-24 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -2.490 183.217 -1,34 132,54 -330.031 24.284.058
2018-04-26 2018-04-24 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1.500 185.707 -0,80 131,76 -197.635 24.468.141
2018-04-26 2018-04-24 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1.283 187.207 -0,68 130,62 -167.590 24.453.577
2018-04-26 2018-04-24 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1.717 188.490 -0,90 129,35 -222.097 24.381.483
2018-04-26 2018-04-24 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 7.500 190.207 4,10 1,18 8.880 225.205
2018-03-15 2018-03-14 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise X -7.500 44.690 -14,37
2018-03-15 2018-03-14 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1.400 182.707 -0,76 132,26 -185.157 24.163.914
2018-03-15 2018-03-14 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -4.300 184.107 -2,28 131,60 -565.873 24.228.168
2018-03-15 2018-03-14 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1.800 188.407 -0,95 130,66 -235.185 24.616.957
2018-03-15 2018-03-14 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 7.500 190.207 4,10 1,18 8.880 225.205
2018-03-15 2018-03-13 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise X -7.500 52.190 -12,56
2018-03-15 2018-03-13 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1.491 182.707 -0,81 133,50 -199.055 24.392.188
2018-03-15 2018-03-13 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1.094 184.198 -0,59 132,58 -145.040 24.420.621
2018-03-15 2018-03-13 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1.715 185.292 -0,92 131,76 -225.968 24.414.018
2018-03-15 2018-03-13 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1.800 187.007 -0,95 130,69 -235.243 24.440.057
2018-03-15 2018-03-13 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1.100 188.807 -0,58 129,97 -142.963 24.538.585
2018-03-15 2018-03-13 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -300 189.907 -0,16 128,57 -38.572 24.416.970
2018-03-15 2018-03-13 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 7.500 190.207 4,10 1,18 8.880 225.205
2018-02-14 2018-02-13 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise X -7.500 59.690 -11,16
2018-02-14 2018-02-13 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -700 182.707 -0,38 102,20 -71.542 18.673.185
2018-02-14 2018-02-13 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -3.996 183.407 -2,13 101,19 -404.350 18.558.734
2018-02-14 2018-02-13 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -791 187.403 -0,42 100,33 -79.365 18.802.968
2018-02-14 2018-02-13 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -400 188.194 -0,21 98,62 -39.449 18.560.163
2018-02-14 2018-02-13 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -100 188.594 -0,05 97,14 -9.714 18.320.021
2018-02-14 2018-02-13 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -413 188.694 -0,22 96,47 -39.843 18.203.650
2018-02-14 2018-02-13 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1.100 189.107 -0,58 94,44 -103.889 17.860.116
2018-02-14 2018-02-13 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 7.500 190.207 4,10 1,18 8.880 225.205
2018-02-14 2018-02-12 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise X -7.500 67.190 -10,04
2018-02-14 2018-02-12 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1.101 182.707 -0,60 94,68 -104.247 17.299.466
2018-02-14 2018-02-12 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -3.942 183.808 -2,10 93,77 -369.642 17.235.695
2018-02-14 2018-02-12 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1.207 187.750 -0,64 92,61 -111.785 17.388.260
2018-02-14 2018-02-12 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1.250 188.957 -0,66 91,76 -114.703 17.339.129
2018-02-14 2018-02-12 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 7.500 190.207 4,10 1,18 8.880 225.205
2018-01-18 2018-01-17 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise X -7.500 74.690 -9,13
2018-01-18 2018-01-17 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -2.682 182.707 -1,45 89,52 -240.106 16.356.826
2018-01-18 2018-01-17 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -2.672 185.389 -1,42 88,89 -237.520 16.479.618
2018-01-18 2018-01-17 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1.042 188.061 -0,55 87,14 -90.802 16.387.936
2018-01-18 2018-01-17 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1.104 189.103 -0,58 86,19 -95.157 16.299.336
2018-01-18 2018-01-17 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 7.500 190.207 4,10 1,18 8.880 225.205
2018-01-18 2018-01-16 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise X -7.500 82.190 -8,36
2018-01-18 2018-01-16 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -800 182.707 -0,44 90,50 -72.397 16.534.326
2018-01-18 2018-01-16 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1.577 183.507 -0,85 89,94 -141.833 16.504.381
2018-01-18 2018-01-16 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -600 185.084 -0,32 88,78 -53.266 16.431.147
2018-01-18 2018-01-16 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1.604 185.684 -0,86 87,12 -139.748 16.177.626
2018-01-18 2018-01-16 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -2.919 187.288 -1,53 86,42 -252.270 16.186.103
2018-01-18 2018-01-16 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 7.500 190.207 4,10 1,18 8.880 225.205
2018-01-05 2018-01-04 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
A - Award 300.000 300.000
2017-12-18 2017-12-15 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise X -7.500 89.690 -7,72
2017-12-18 2017-12-15 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -200 182.707 -0,11 82,86 -16.572 15.139.102
2017-12-18 2017-12-15 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -100 182.907 -0,05 81,72 -8.172 14.947.160
2017-12-18 2017-12-15 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -600 183.007 -0,33 80,88 -48.529 14.801.917
2017-12-18 2017-12-15 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -609 183.607 -0,33 80,08 -48.770 14.703.652
2017-12-18 2017-12-15 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -3.023 184.216 -1,61 78,99 -238.796 14.551.811
2017-12-18 2017-12-15 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -2.268 187.239 -1,20 78,06 -177.050 14.616.719
2017-12-18 2017-12-15 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -700 189.507 -0,37 76,93 -53.849 14.578.224
2017-12-18 2017-12-15 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 7.500 190.207 4,10 1,18 8.880 225.205
2017-12-18 2017-12-14 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise X -7.500 97.190 -7,16
2017-12-18 2017-12-14 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -2.000 182.707 -1,08 84,29 -168.587 15.401.013
2017-12-18 2017-12-14 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -2.900 184.707 -1,55 83,42 -241.912 15.407.870
2017-12-18 2017-12-14 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -2.600 187.607 -1,37 82,55 -214.621 15.486.301
2017-12-18 2017-12-14 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 7.500 190.207 4,10 1,18 8.880 225.205
2017-11-29 2017-11-28 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise X -7.500 104.690 -6,69
2017-11-29 2017-11-28 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -790 182.707 -0,43 75,85 -59.923 13.858.764
2017-11-29 2017-11-28 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1.850 183.497 -1,00 75,21 -139.138 13.800.718
2017-11-29 2017-11-28 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -2.460 185.347 -1,31 73,99 -182.024 13.714.492
2017-11-29 2017-11-28 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -2.400 187.807 -1,26 73,15 -175.563 13.738.326
2017-11-29 2017-11-28 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 7.500 190.207 4,10 1,18 8.880 225.205
2017-11-29 2017-11-27 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise X -7.500 112.190 -6,27
2017-11-29 2017-11-27 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -300 182.707 -0,16 77,07 -23.122 14.081.831
2017-11-29 2017-11-27 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -906 183.007 -0,49 76,20 -69.036 13.944.932
2017-11-29 2017-11-27 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1.601 183.913 -0,86 74,98 -120.049 13.790.496
2017-11-29 2017-11-27 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -4.693 185.514 -2,47 74,13 -347.893 13.752.190
2017-11-29 2017-11-27 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 7.500 190.207 4,10 1,18 8.880 225.205
2017-11-29 2017-11-20 4 LOXO Loxo Oncology, Inc.
Common Stock
G - Gift -6.000 182.707 -3,18
2017-11-01 2017-10-31 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise X -7.500 119.690 -5,90
2017-11-01 2017-10-31 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -200 188.707 -0,11 87,66 -17.533 16.542.999
2017-11-01 2017-10-31 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -4.339 188.907 -2,25 86,65 -375.994 16.369.642
2017-11-01 2017-10-31 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -2.961 193.246 -1,51 86,18 -255.175 16.653.708
2017-11-01 2017-10-31 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 7.500 196.207 3,97 1,18 8.880 232.309
2017-11-01 2017-10-30 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise X -7.500 127.190 -5,57
2017-11-01 2017-10-30 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -812 188.707 -0,43 88,77 -72.084 16.752.219
2017-11-01 2017-10-30 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -998 189.519 -0,52 87,74 -87.563 16.628.132
2017-11-01 2017-10-30 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -5.690 190.517 -2,90 86,88 -494.320 16.551.202
2017-11-01 2017-10-30 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 7.500 196.207 3,97 1,18 8.880 232.309
2017-09-20 2017-09-19 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise X -7.500 134.690 -5,27
2017-09-20 2017-09-19 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -2.263 188.707 -1,19 89,48 -202.485 16.884.823
2017-09-20 2017-09-19 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -2.873 190.970 -1,48 89,03 -255.781 17.001.906
2017-09-20 2017-09-19 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -2.364 193.843 -1,20 87,82 -207.604 17.023.060
2017-09-20 2017-09-19 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 7.500 196.207 3,97 1,18 8.880 232.309
2017-09-20 2017-09-18 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise X -7.500 142.190 -5,01
2017-09-20 2017-09-18 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -200 188.707 -0,11 90,56 -18.111 17.088.362
2017-09-20 2017-09-18 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -2.817 188.907 -1,47 89,88 -253.179 16.978.092
2017-09-20 2017-09-18 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -3.379 191.724 -1,73 89,09 -301.042 17.081.094
2017-09-20 2017-09-18 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1.104 195.103 -0,56 87,93 -97.074 17.155.290
2017-09-20 2017-09-18 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 7.500 196.207 3,97 1,18 8.880 232.309
2017-08-16 2017-08-15 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise X -7.500 149.690 -4,77
2017-08-16 2017-08-15 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -936 188.707 -0,49 73,83 -69.109 13.933.106
2017-08-16 2017-08-15 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -6.564 189.643 -3,35 73,33 -481.334 13.906.388
2017-08-16 2017-08-15 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 7.500 196.207 3,97 1,18 8.880 232.309
2017-08-16 2017-08-14 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise X -7.500 157.190 -4,55
2017-08-16 2017-08-14 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -2.483 188.707 -1,30 74,12 -184.046 13.987.453
2017-08-16 2017-08-14 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -5.017 191.190 -2,56 73,54 -368.959 14.060.457
2017-08-16 2017-08-14 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 7.500 196.207 3,97 1,18 8.880 232.309
2017-03-17 2017-03-15 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
A - Award 100.000 100.000
2016-12-08 2016-12-06 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
A - Award 209.000 209.000
2016-09-15 2016-09-13 4 VRAY ViewRay, Inc.
Common Stock
A - Award 18.964 18.964
2016-06-21 2016-06-17 4 TTOO T2 Biosystems, Inc.
Stock Option (Right to Buy)
A - Award 17.647 17.647
2016-03-30 3 VRAY ViewRay, Inc.
Common Stock
14.923.846
2016-03-30 3 VRAY ViewRay, Inc.
Common Stock
14.923.846
2015-12-18 2015-12-16 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
A - Award 142.000 142.000
2015-06-23 2015-06-19 4 TTOO T2 Biosystems, Inc.
Stock Option (Right to Buy)
A - Award 17.647 17.647
2014-12-23 2014-12-19 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
A - Award 350.000 350.000
2014-07-31 3 LOXO Loxo Oncology, Inc.
Common Stock
377.414
2014-07-31 3 LOXO Loxo Oncology, Inc.
Common Stock
377.414
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)